These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice. Han WR, Zhan Y, Murray-Segal LJ, Brady JL, Lew AM, Mottram PL. Transplantation; 2000 Jul 15; 70(1):168-74. PubMed ID: 10919596 [Abstract] [Full Text] [Related]
5. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. Orosz CG, Huang EH, Bergese SD, Sedmak DD, Birmingham DJ, Ohye RG, VanBuskirk AM. J Heart Lung Transplant; 1997 Sep 15; 16(9):889-904. PubMed ID: 9322138 [Abstract] [Full Text] [Related]
6. Graft endothelial VCAM-1 is not necessary for acute cardiac allograft rejection in mice. Bergese SD, Pelletier RP, Ferguson RM, Orosz CG. Transplant Proc; 1995 Feb 15; 27(1):480-1. PubMed ID: 7533417 [No Abstract] [Full Text] [Related]
7. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival. Cho HR, Kwon B, Yagita H, La S, Lee EA, Kim JE, Akiba H, Kim J, Suh JH, Vinay DS, Ju SA, Kim BS, Mittler RS, Okumura K, Kwon BS. Transpl Int; 2004 Aug 15; 17(7):351-61. PubMed ID: 15349720 [Abstract] [Full Text] [Related]
8. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model. Ito H, Hamano K, Fukumoto T, Wood KJ, Esato K. J Heart Lung Transplant; 1998 May 15; 17(5):460-9. PubMed ID: 9628564 [Abstract] [Full Text] [Related]
9. Tolerance induction with anti-CD8 monoclonal antibodies in the mouse heart transplant model. Mottram PL, Purcell LJ, Pietersz GA, McKenzie IF. Transplant Proc; 1993 Oct 15; 25(5):2935-6. PubMed ID: 8212289 [No Abstract] [Full Text] [Related]
11. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities. Youssef AR, Otley C, Mathieson PW, Smith RM. Transpl Immunol; 2004 Dec 15; 13(4):297-304. PubMed ID: 15589743 [Abstract] [Full Text] [Related]
12. Anti-T cell monoclonal antibodies for in vivo treatment of cardiac allograft rejection in mice. Mottram PL, Smyth M, Pietersz GA, Clunie GJ, McKenzie IF. Transplant Proc; 1989 Feb 15; 21(1 Pt 1):1020-1. PubMed ID: 2650063 [No Abstract] [Full Text] [Related]
13. Immunosuppression by aminopterin or idarubicin conjugated to anti-CD8 in the mouse heart allograft model. Mottram PL, Pietersz GA, Purcell LJ, Krauer K, McKenzie IF. Transplant Proc; 1992 Oct 15; 24(5):2301. PubMed ID: 1413068 [No Abstract] [Full Text] [Related]
14. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice. Cai Y, Tang XD, Zhou PJ. Scand J Immunol; 2005 Mar 15; 61(3):266-73. PubMed ID: 15787744 [Abstract] [Full Text] [Related]
15. Induction of operational tolerance and generation of regulatory cells after intratracheal delivery of alloantigen combined with nondepleting anti-CD4 monoclonal antibody. Aramaki O, Shirasugi N, Akiyama Y, Takayama T, Shimazu M, Kitajima M, Ikeda Y, Niimi M. Transplantation; 2003 Nov 15; 76(9):1305-14. PubMed ID: 14627908 [Abstract] [Full Text] [Related]
19. The effect of a depleting anti-CD4 monoclonal antibody on T cells and fetal pig islet xenograft survival in various strains of mice. Mandel T, Dillon H, Koulmanda M. Transplant Proc; 1995 Dec 15; 27(6):3569. PubMed ID: 8540105 [No Abstract] [Full Text] [Related]
20. Combined application of blocking antibodies and MicroRNA interference in inhibiting CD44 expression. Shao W, Chen JB, Wang F, Xia JJ, Qi ZQ. Transplant Proc; 2010 Sep 15; 42(7):2777-81. PubMed ID: 20832586 [Abstract] [Full Text] [Related] Page: [Next] [New Search]